Skip to main content

The latest developments in oncology research

The long list of new treatments reflects the advent of cancer immunotherapy as well as continued progress in matching treatment to genetics. New drugs for lung, breast, skin and blood cancers have made gains over standard of care, while other additions have expanded options for patients.

included in this trendline
  • ‘Dramatic’ study results for AstraZeneca, Daiichi drug suggest new way to treat aggressive breast cancer
  • With spotlight on FDA, Congress weighs reforms to accelerated drug approvals
  • CAR-T treatment moves earlier as FDA widens approval of Gilead’s Yescarta
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.